CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: RUFY3 (ImmuneEditome ID:22902)

1. Gene summary of enriched editing regions for RUFY3

check button Gene summary
Gene informationGene symbol

RUFY3

Gene ID

22902

GeneSynonymsRIPX|SINGAR1|ZFYVE30
GeneCytomap

4q13.3

GeneTypeprotein-coding
GeneDescriptionprotein RUFY3|rap2 interacting protein x|single axon-regulated protein|single axon-related 1
GeneModificationdate20230329
UniprotIDQ7L099;D6REM9;D6RCQ1;D6RH24
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr4:70707989-70709036:+ENST00000417478.5ENSG00000018189.11RUFY3intronicAluJo,AluJb,AluSzchr4:70707989-70709036:+.alignment
chr4:70707989-70709036:+ENST00000503876.4ENSG00000018189.11RUFY3intronicAluJo,AluJb,AluSzchr4:70707989-70709036:+.alignment
chr4:70715359-70716638:+ENST00000417478.5ENSG00000018189.11RUFY3intronicAluSz,AluSq2,L1ME3F,AluSc8chr4:70715359-70716638:+.alignment
chr4:70715359-70716638:+ENST00000503876.4ENSG00000018189.11RUFY3intronicAluSz,AluSq2,L1ME3F,AluSc8chr4:70715359-70716638:+.alignment
chr4:70720142-70721267:+ENST00000417478.5ENSG00000018189.11RUFY3intronicAluSq,(GT)n,AluSx4,AluSg7chr4:70720142-70721267:+.alignment
chr4:70720142-70721267:+ENST00000503876.4ENSG00000018189.11RUFY3intronicAluSq,(GT)n,AluSx4,AluSg7chr4:70720142-70721267:+.alignment
chr4:70796945-70799080:+ENST00000503025.4ENSG00000018189.11RUFY3ncRNA_intronicAluJb,AluSx,AluJo,HSMAR2,AluSx1,Tigger20achr4:70796945-70799080:+.alignment
chr4:70796945-70799080:+ENST00000507333.4ENSG00000018189.11RUFY3ncRNA_intronicAluJb,AluSx,AluJo,HSMAR2,AluSx1,Tigger20achr4:70796945-70799080:+.alignment


Top

2. Tumor-specific enriched editing regions for RUFY3


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
chr4:70796945-70799080:+THCAEER4.6319e-02image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
chr4:70796945-70799080:+PAADPathEER3.8668e-024.2497e-020.3608image
ENSG00000018189.11,RUFY3PAADPathEAG3.8668e-024.2497e-020.3608image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for RUFY3


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

4. Enriched editing regions and immune related splicing for RUFY3


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
ENSG00000018189.11,RUFY3
ESCAEAGA3ENSG00000159166.9chr1201383073:201383208:201382652:201382686:201382652:2013828050.15893.1162e-022.1585e-050.4149imageNAUH;BCCIP;BUD13;CSTF2T;DDX54;DGCR8;DKC1;EIF4A3;ELAVL1;FAM120A;FBL;FUS;GTF2F1;HNRNPA1;HNRNPC;HNRNPK;HNRNPL;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;LIN28B;NOP58;PCBP2;PRPF8;RBFOX2;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;YTHDC1NANK_cells_activatedGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING
ENSG00000018189.11,RUFY3
ESCAEAGA3ENSG00000119446.9chr9122264714:122264794:122261379:122261498:122261379:1222615080.43921.0973e-031.2407e-080.4788imageNAUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHSRP;LARP4B;LIN28;LIN28B;LSM11;MBNL2;MOV10;MSI1;MSI2;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM47;RBM5;SAFB2;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;ZC3H7B;ZNF184NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_GLYCOLYSIS
chr4:70796945-70799080:+
ESCAEERIRENSG00000131981.11chr1455129043:55129300:55133210:551333920.30364.4114e-023.9595e-050.4234imageNDKC1LGALS3Macrophages_M1GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION
ENSG00000018189.11,RUFY3
ESCAEAGESENSG00000152465.13chr1015128349:15128458:15130141:15130312:15132816:15132933-0.34392.4176e-024.9634e-06-0.4001imageNADAR;AIFM1;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;EIF4G2;ELAVL1;ELAVL3;FAM120A;FBL;FMR1;FTO;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHSRP;LIN28;LIN28B;LSM11;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM47;RBM5;RNF219;SAFB2;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TRA2A;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;ZNF184NANK_cells_activatedGSVA_HALLMARK_COMPLEMENT
chr4:70796945-70799080:+
ESCAEERA3ENSG00000119446.9chr9122264714:122264794:122261379:122261498:122261379:1222615080.39501.2105e-021.4962e-060.4262imageNDKC1NAT_cells_regulatory_(Tregs)GSVA_HALLMARK_GLYCOLYSIS

More results



Top

5. Enriched editing regions and immune infiltration for RUFY3


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
ENSG00000018189.11,RUFY3BLCAEAGMacrophages_M01.4402e-030.6024image
chr4:70796945-70799080:+BRCAEERT_cells_CD4_memory_resting1.9346e-020.1293image
chr4:70796945-70799080:+CESCEERDendritic_cells_resting1.1924e-020.3801image
ENSG00000018189.11,RUFY3CESCEAGDendritic_cells_resting1.1923e-020.3718image
chr4:70796945-70799080:+ESCAEERT_cells_regulatory_(Tregs)5.7953e-03-0.2526image
ENSG00000018189.11,RUFY3ESCAEAGT_cells_regulatory_(Tregs)2.7709e-03-0.2624image
chr4:70796945-70799080:+GBMEERT_cells_CD85.1264e-030.3082image
ENSG00000018189.11,RUFY3GBMEAGT_cells_CD84.5488e-030.3122image
chr4:70796945-70799080:+KICHEERNeutrophils3.4443e-030.4570image
ENSG00000018189.11,RUFY3KICHEAGNeutrophils3.2750e-030.4592image
ENSG00000018189.11,RUFY3LAMLEAGT_cells_CD4_naive3.8429e-020.2908image
chr4:70796945-70799080:+LGGEERNK_cells_activated5.9257e-04-0.2720image
ENSG00000018189.11,RUFY3LGGEAGNK_cells_activated1.9120e-04-0.2908image
chr4:70796945-70799080:+LUADEERNK_cells_activated4.3473e-02-0.1862image
ENSG00000018189.11,RUFY3LUADEAGNK_cells_activated4.2443e-02-0.1818image
chr4:70796945-70799080:+LUSCEERT_cells_follicular_helper3.2515e-020.2698image
ENSG00000018189.11,RUFY3LUSCEAGT_cells_follicular_helper3.5651e-020.2652image
chr4:70715359-70716638:+OVEERMacrophages_M14.5856e-020.2927image
chr4:70796945-70799080:+OVEERNK_cells_activated8.9180e-030.2129image
ENSG00000018189.11,RUFY3OVEAGNK_cells_activated2.1578e-020.1816image
chr4:70796945-70799080:+PCPGEERDendritic_cells_activated1.7319e-030.3757image
ENSG00000018189.11,RUFY3PCPGEAGDendritic_cells_activated1.6132e-030.3780image
ENSG00000018189.11,RUFY3PRADEAGMacrophages_M15.3066e-030.5124image
chr4:70796945-70799080:+SKCMEERT_cells_CD4_memory_activated4.1528e-040.4106image
ENSG00000018189.11,RUFY3SKCMEAGT_cells_CD4_memory_activated4.1997e-040.4075image
chr4:70715359-70716638:+STADEERNK_cells_resting1.3935e-030.4002image
chr4:70720142-70721267:+STADEERT_cells_CD4_memory_activated9.4785e-030.5288image
chr4:70796945-70799080:+STADEERT_cells_CD4_memory_resting1.2769e-02-0.1906image
ENSG00000018189.11,RUFY3STADEAGT_cells_CD4_memory_activated2.4664e-030.2109image
chr4:70796945-70799080:+THCAEERB_cells_memory4.2417e-020.1203image
ENSG00000018189.11,RUFY3THYMEAGPlasma_cells9.1978e-03-0.5306image
ENSG00000018189.11,RUFY3UCECEAGT_cells_gamma_delta3.7617e-030.5794image


Top

6. Enriched editing regions and immune gene sets for RUFY3


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000018189.11,RUFY3ACCGSVA_HALLMARK_HYPOXIAEAG1.4769e-020.5015image
chr4:70796945-70799080:+ACCGSVA_HALLMARK_HYPOXIAEER1.2777e-020.5107image
ENSG00000018189.11,RUFY3BLCAGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEAG1.6177e-020.4760image
ENSG00000018189.11,RUFY3BRCAGSVA_HALLMARK_PROTEIN_SECRETIONEAG2.8342e-050.2250image
chr4:70796945-70799080:+BRCAGSVA_HALLMARK_PROTEIN_SECRETIONEER3.0056e-040.1987image
ENSG00000018189.11,RUFY3CESCGSVA_HALLMARK_APOPTOSISEAG2.3240e-020.3378image
chr4:70796945-70799080:+ESCAGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEER3.1350e-020.1983image
ENSG00000018189.11,RUFY3ESCAGSVA_HALLMARK_HYPOXIAEAG1.4203e-020.2163image
ENSG00000018189.11,RUFY3KICHGSVA_HALLMARK_ADIPOGENESISEAG1.1700e-020.3997image
chr4:70796945-70799080:+KICHGSVA_HALLMARK_ADIPOGENESISEER1.1667e-020.3999image
ENSG00000018189.11,RUFY3KIRCGSVA_HALLMARK_MYC_TARGETS_V1EAG7.4450e-030.1788image
chr4:70796945-70799080:+KIRCGSVA_HALLMARK_MYC_TARGETS_V1EER3.4915e-020.1426image
chr4:70796945-70799080:+KIRPGSVA_HALLMARK_MITOTIC_SPINDLEEER1.6262e-020.2500image
ENSG00000018189.11,RUFY3KIRPGSVA_HALLMARK_ESTROGEN_RESPONSE_EARLYEAG2.0057e-020.2395image
ENSG00000018189.11,RUFY3LAMLGSVA_HALLMARK_MITOTIC_SPINDLEEAG2.1688e-03-0.4197image
ENSG00000018189.11,RUFY3LGGGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG9.6681e-03-0.2040image
chr4:70796945-70799080:+LGGGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER3.8866e-02-0.1656image
ENSG00000018189.11,RUFY3LUSCGSVA_HALLMARK_MYC_TARGETS_V1EAG6.2740e-030.3408image
chr4:70796945-70799080:+LUSCGSVA_HALLMARK_G2M_CHECKPOINTEER5.5352e-030.3456image
chr4:70715359-70716638:+OVGSVA_HALLMARK_IL6_JAK_STAT3_SIGNALINGEER1.4037e-040.5272image
ENSG00000018189.11,RUFY3OVGSVA_HALLMARK_PEROXISOMEEAG6.2917e-030.2152image
chr4:70796945-70799080:+OVGSVA_HALLMARK_PEROXISOMEEER1.2922e-020.2026image
ENSG00000018189.11,RUFY3PCPGGSVA_HALLMARK_KRAS_SIGNALING_DNEAG7.3880e-03-0.3245image
chr4:70796945-70799080:+PCPGGSVA_HALLMARK_KRAS_SIGNALING_DNEER1.2224e-02-0.3045image
ENSG00000018189.11,RUFY3PRADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.7035e-030.5451image
ENSG00000018189.11,RUFY3SARCGSVA_HALLMARK_MYOGENESISEAG3.8738e-020.2904image
chr4:70796945-70799080:+SARCGSVA_HALLMARK_G2M_CHECKPOINTEER2.2367e-02-0.3225image
ENSG00000018189.11,RUFY3SKCMGSVA_HALLMARK_BILE_ACID_METABOLISMEAG3.9592e-02-0.2448image
chr4:70796945-70799080:+SKCMGSVA_HALLMARK_BILE_ACID_METABOLISMEER3.5867e-02-0.2513image
ENSG00000018189.11,RUFY3STADGSVA_HALLMARK_SPERMATOGENESISEAG2.6957e-040.2525image
chr4:70796945-70799080:+STADGSVA_HALLMARK_SPERMATOGENESISEER1.0239e-020.1965image
chr4:70796945-70799080:+THCAGSVA_HALLMARK_MITOTIC_SPINDLEEER2.9544e-040.2129image
ENSG00000018189.11,RUFY3THCAGSVA_HALLMARK_MITOTIC_SPINDLEEAG1.0657e-040.2244image
ENSG00000018189.11,RUFY3THYMGSVA_HALLMARK_ANDROGEN_RESPONSEEAG2.7826e-040.6888image
ENSG00000018189.11,RUFY3UCECGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG3.3174e-020.4454image


Top

7. Enriched editing regions and drugs for RUFY3


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
chr4:70796945-70799080:+ACCAZD6244EER1.0964e-02-0.5201image
ENSG00000018189.11,RUFY3ACCABT.888EAG1.1466e-02-0.5174image
ENSG00000018189.11,RUFY3BLCAJNJ.26854165EAG1.1738e-02-0.4957image
ENSG00000018189.11,RUFY3BRCAAxitinibEAG3.3475e-030.1589image
chr4:70796945-70799080:+BRCABMS.708163EER1.1942e-03-0.1787image
chr4:70796945-70799080:+ESCABryostatin.1EER9.7649e-03-0.2370image
ENSG00000018189.11,RUFY3ESCABryostatin.1EAG2.0379e-02-0.2048image
ENSG00000018189.11,RUFY3GBMAS601245EAG4.3332e-020.2251image
chr4:70796945-70799080:+GBMBIBW2992EER4.8688e-020.2198image
ENSG00000018189.11,RUFY3KICHErlotinibEAG1.7055e-03-0.4861image
chr4:70796945-70799080:+KICHErlotinibEER2.0859e-03-0.4780image
ENSG00000018189.11,RUFY3KIRCLFM.A13EAG5.9082e-030.1838image
chr4:70796945-70799080:+KIRCLFM.A13EER6.7627e-030.1825image
ENSG00000018189.11,RUFY3KIRPCHIR.99021EAG9.0785e-03-0.2678image
chr4:70796945-70799080:+KIRPCHIR.99021EER6.2368e-03-0.2832image
ENSG00000018189.11,RUFY3LAMLAZD8055EAG1.8310e-02-0.3293image
chr4:70796945-70799080:+LGGGW843682XEER5.0271e-030.2236image
ENSG00000018189.11,RUFY3LGGAZD6482EAG6.2239e-04-0.2677image
chr4:70796945-70799080:+LUADA.770041EER1.7931e-030.2845image
ENSG00000018189.11,RUFY3LUADBMS.708163EAG1.5438e-02-0.2162image
ENSG00000018189.11,RUFY3LUSCCGP.082996EAG5.9237e-03-0.3430image
chr4:70796945-70799080:+LUSCCGP.082996EER6.2412e-03-0.3410image
ENSG00000018189.11,RUFY3OVBIBW2992EAG1.3808e-02-0.1943image
chr4:70715359-70716638:+OVCI.1040EER1.0954e-02-0.3679image
chr4:70796945-70799080:+OVIPA.3EER3.7133e-020.1704image
ENSG00000018189.11,RUFY3PCPGDMOGEAG1.3455e-020.3006image
chr4:70796945-70799080:+PCPGDMOGEER1.5329e-020.2951image
ENSG00000018189.11,RUFY3PRADCamptothecinEAG1.6141e-02-0.4505image
ENSG00000018189.11,RUFY3SARCBIRB.0796EAG1.9464e-020.3263image
chr4:70796945-70799080:+SARCGNF.2EER8.9859e-03-0.3658image
ENSG00000018189.11,RUFY3SKCMBAY.61.3606EAG7.8917e-03-0.3129image
chr4:70796945-70799080:+SKCMBAY.61.3606EER7.7108e-03-0.3159image
ENSG00000018189.11,RUFY3STADAG.014699EAG2.6939e-030.2090image
chr4:70720142-70721267:+STADBleomycinEER1.2222e-02-0.5134image
chr4:70796945-70799080:+STADAG.014699EER1.7710e-020.1817image
chr4:70715359-70716638:+STADBX.795EER3.6915e-020.2678image
chr4:70796945-70799080:+THCAAICAREER4.4062e-03-0.1682image
ENSG00000018189.11,RUFY3THCABMS.708163EAG1.7991e-03-0.1816image
ENSG00000018189.11,RUFY3THYMBX.795EAG2.3304e-03-0.6028image
ENSG00000018189.11,RUFY3UCECBMS.754807EAG8.4057e-03-0.5358image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType